Cystic fibrosis (CF) patients frequently suffer from chronic rhinosinusitis (CRS). The extent to which alterations in sinonasal innate immunity contribute to this disease process is unknown. Activation of sinonasal epithelial cell (SNEC) Toll-like receptors (TLRs), an important component of the innate immune system, may be associated with the hyperinflammatory state observed in sinonasal mucosa of CF patients with CRS. This study compares expression of Toll-like receptor 9 (TLR9), in SNRCs collected from CF subjects with CRS to that of normal control subjects.
Methods
This was a prospective study measuring TLR9 on SNECs collected via endoscopic-guided middle meatal brushings from 8 adult controls and 14 adult subjects with CF-associated CRS.
Results
TLR9 expression was significantly elevated in CF subjects at 91% ± 6% when compared with 76% ± 10% in normal controls (p = 0.001).
Conclusion
The significantly greater expression of sinonasal epithelial TLR9 in CF likely reflects increased antimicrobial innate immune activity in chronically colonized and frequently infected CF individuals. However, this finding contrasts with previously reported decreased epithelial TLR9 expression in eosinophilic CRS with nasal polyposis and may indicate differential modulation of innate immunity in Th1-predominent F versus Th2-dominated CRS with nasal polyps, despite both being diseases of sinonasal mucosal inflammation.
Get full access to this article
View all access options for this article.
References
1.
BergoinC., GossetP., LamblinC.. Cell and cytokine profile in nasal secretions in cystic fibrosis.J Cyst Fibros1: 110–115, 2002.
2.
ClaeysS., Van HoeckeH., HoltappelsG.. Nasal polyps in patients with and without cystic fibrosis: A differentiation by innate markers and inflammatory mediators.Clin Exp Allergy35: 467–472, 2005.
3.
RobertsonJ.M., FriedmanE.M., and RubinB.K.. Nasal and sinus disease in cystic fibrosis.Paediatr Respir Rev9: 213–219, 2008.
4.
SchravenS.P., WehrmannM., WagnerW.. Prevalence and histopathology of chronic polypoid sinusitis in pediatric patients with cystic fibrosis.J Cyst Fibros10: 181–186, 2011.
5.
AprilM.M.. Management of chronic sinusitis in children with cystic fibrosis.Pediatr Pulmonol Suppl18: 76–77, 1999.
6.
ColtreraM.D., MathisonS.M., GoodpasterT.A., and GownA.M.. Abnormal expression of the cystic fibrosis transmembrane regulator in chronic sinusitis in cystic fibrosis and non-cystic fibrosis patients.Ann Otol Rhinol Laryngol108: 576–581, 1999.
7.
DavidsonT.M., MurphyC., MitchellM.. Management of chronic sinusitis in cystic fibrosis.Laryngoscope105: 354–358, 1995.
8.
GodoyJ.M., GodoyA.N., RibaltaG., and LargoI.. Bacterial pattern in chronic sinusitis and cystic fibrosis.Otolaryngol Head Neck Surg145: 673–676, 2011.
9.
HalvorsonD.J., DupreeJ.R., and PorubskyE.S.. Management of chronic sinusitis in the adult cystic fibrosis patient.Ann Otol Rhinol Laryngol107: 946–952, 1998.
10.
HytönenM., PatjasM., VentoS.I.. Cystic fibrosis gene mutations deltaF508 and 394delTT in patients with chronic sinusitis in Finland.Acta Otolaryngol121: 945–947, 2001.
11.
KimH.J., FriedmanE.M., SulekM.. Paranasal sinus development in chronic sinusitis, cystic fibrosis, and normal comparison population: A computerized tomography correlation study.Am J Rhinol11: 275–281, 1997.
12.
MackayI.S., and DjazaeriB.. Chronic sinusitis in cystic fibrosis.J R Soc Med87(suppl 21): 17–19, 1994.
13.
MainzJ.G., and KoitschevA.. Management of chronic rhinosinusitis in CF.J Cyst Fibros8(suppl 1): S10–S14, 2009.
14.
NunesF.B., CastroM.C., SilvaT.M.. Cytokine profile in subjects with cystic fibrosis and nasal polyposis compared to patients with no nasal disorders.Braz J Otorhinolaryngol76: 25–28, 2010.
15.
RaynorE.M., ButlerA., GuillM., and BentJP3rd. Nasally inhaled dornase alfa in the postoperative management of chronic sinusitis due to cystic fibrosis.Arch Otolaryngol Head Neck Surg126: 581–583, 2000.
16.
SkinnerM.L., SchlosserR.J., LathersD.. Innate and adaptive mediators in cystic fibrosis and allergic fungal rhinosinusitis.Am J Rhinol21: 538–541, 2007.
17.
SobolS.E., ChristodoulopoulosP., ManoukianJ.J.. Cytokine profile of chronic sinusitis in patients with cystic fibrosis.Arch Otolaryngol Head Neck Surg128: 1295–1298, 2002.
18.
WagnerJ.A., MoranM.L., MessnerA.H.. A phase I/II study of tgAAV-CF for the treatment of chronic sinusitis in patients with cystic fibrosis.Hum Gene Ther9: 889–909, 1998.
19.
YeagerM.J., KakumanuS., and CraigT.J.. Chronic sinusitis in patients with cystic fibrosis.J Am Osteopath Assoc99: S6–S8, 1999.
20.
RamanathanM.Jr., and LaneA.P.. Innate immunity of the sinonasal cavity and its role in chronic rhinosinusitis.Otolaryngol Head Neck Surg136: 348–356, 2007.
21.
GoldsteinD.R.. Toll-like receptors and other links between innate and acquired alloimmunity.Curr Opin Immunol16: 538–544, 2004.
22.
VandermeerJ., ShaQ., LaneA.P., and SchleimerR.P.. Innate immunity of the sinonasal cavity: Expression of messenger RNA for complement cascade components and toll-like receptors.Arch Otolaryngol Head Neck Surg130: 1374–1380, 2004.
23.
MelvinT.A., LaneA.P., NguyenM.T., and LinS.Y.. Allergic rhinitis patients with recurrent acute sinusitis have increased sinonasal epithelial cell TLR9 expression.Otolaryngol Head Neck Surg142: 659–664, 2010.
24.
CreticosP.S., SchroederJ.T., HamiltonR.G.. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis.N Engl J Med355: 1445–1455, 2006.
25.
TanL., RogersT.J., HatzirodosN.. Immunomodulatory effect of cytosine-phosphate-guanosine (CpG)-oligonucleotides in nonasthmatic chronic rhinosinusitis: An explant model.Am J Rhinol Allergy23: 123–129, 2009.
26.
BlohmkeC.J., VictorR.E., HirschfeldA.F.. Innate immunity mediated by TLR5 as a novel antiinflammatory target for cystic fibrosis lung disease.J Immunol180: 7764–7773, 2008.
27.
BuchananP.J., ErnstR.K., ElbornJ.S., and SchockB.. Role of CFTR, Pseudomonas aeruginosa and Toll-like receptors in cystic fibrosis lung inflammation.Biochem Soc Trans37: 863–867, 2009.
28.
ArmstrongL., MedfordA.R., UppingtonK.M.. Expression of functional toll-like receptor-2 and -4 on alveolar epithelial cells.Am J Respir Cell Mol Biol31: 241–245, 2004.
29.
ChuH.W., JeyaseelanS., RinoJ.G.. TLR2 signaling is critical for Mycoplasma pneumoniae-induced airway mucin expression.J Immunol174: 5713–5719, 2005.
30.
SunY., ZhouB., WangC.. Biofilm formation and Toll-like receptor 2, Toll-like receptor 4, and NF-kappaB expression in sinus tissues of patients with chronic rhinosinusitis.Am J Rhinol Allergy26: 104–109, 2012.
GreeneC.M., BranaganP., and McElvaneyN.G.. Toll-like receptors as therapeutic targets in cystic fibrosis.Expert Opin Ther Targets12: 1481–1495, 2008.
33.
KobayashiH., HornerA.A., Martin-OrozcoE., and RazE.. Pre-priming: A novel approach to DNA-based vaccination and immunomodulation.Springer Semin Immunopathol22: 85–96, 2000.
34.
AkiraS., UematsuS., and TakeuchiO.. Pathogen recognition and innate immunity.Cell124: 783–801, 2006.
35.
ChuR.S., AskewD., and HardingC.V.. CpG DNA switches on Th1 immunity and modulates antigen-presenting cell function.Curr Top Microbiol Immunol247: 199–210, 2000.
36.
HeegK., and ZimmermannS.. CpG DNA as a Th1 trigger.Int Arch Allergy Immunol121: 87–97, 2000.
KriegA.M., EflerS.M., WittpothM.. Induction of systemic TH1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-class CpG oligodeoxynucleotide TLR9 agonist.J Immunother27: 460–471, 2004.
39.
Van ZeleT., ClaeysS., GevaertP.. Differentiation of chronic sinus diseases by measurement of inflammatory mediators.Allergy61: 1280–1289, 2006.
40.
RosenfeldR.M., AndesD., BhattacharyyaN.. Clinical practice guideline: Adult sinusitis.Otolaryngol Head Neck Surg137: S1–S31, 2007.
41.
RandhawaA.K., and HawnT.R.. Toll-like receptors: Their roles in bacterial recognition and respiratory infections.Expert Rev Anti Infect Ther6: 479–495, 2008.
42.
KollerB., KapplerM., LatzinP.. TLR expression on neutrophils at the pulmonary site of infection: TLR1/TLR2-mediated up-regulation of TLR5 expression in cystic fibrosis lung disease.J Immunol181: 2753–2763, 2008.
43.
JohnG., YildirimA.O., RubinB.K.. TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells.Am J Respir Cell Mol Biol42: 424–431, 2010.
44.
GriffinS., CarrollT.P., GreeneC.M.. Effect of pro-inflammatory stimuli on mucin expression and inhibition by secretory leucoprotease inhibitor.Cell Microbiol9: 670–679, 2007.
45.
RamanathanM.Jr., LeeW.K., DubinM.G.. Sinonasal epithelial cell expression of toll-like receptor 9 is decreased in chronic rhinosinusitis with polyps.Am J Rhinol21: 110–116, 2007.
